. Histograms of p-values in analyses of observational data where we believe the null hypothesis is true. SCCS, self-controlled case series; GE, general electric centricity database; MDCR, MarketScan medicare supplemental beneficiaries database).
More specifically, we developed a set of "negative controls" in a systematic evaluation of the association between hundreds of pharmaceutical products and a set of clinically relevant adverse drug reactions. Our negative controls were drug-outcome pairs for which an expert panel deemed that no evidence of a causal association exists, i.e. we believe the true effect size is zero. We then applied multiple epidemiological designs to generate estimated effect sizes and associated p-values for these negative controls across different large-scale patient-level healthcare databases. Figure 1 shows the histograms for three study designs that are used throughout the medical literature: case-control studies, studies using a cohort method, and self-controlled case series (SCCS) (Farrington, 1995) . Our experiments cover a broad range of outcomes and data sources, but in our discussion here we focus on the application of case-control and SCCS designs to a set of drugs in relation to upper gastro-intestinal bleeding within the general electric (GE) centricity database, a large electronic health record database, and the cohort method to drugs in relation to acute liver failure within the MarketScan Medicare Supplemental Beneficiaries database, a large administrative claims database of retirees who purchase additional insurance to augment their Medicare benefits.
In Figure 1 , we note that the distribution of observed p-values for our negative controls shows severe departures from uniformity, even though we performed no p-value hacking or rounding. This finding suggests that the study estimates themselves are severely biased. Despite the use of advanced epidemiological techniques such as propensity score adjustment (Schneeweiss and others, 2009 ) and self-controlled designs (Farrington and others, 1996) , it seems that we remain unable to sufficiently correct for confounding and other measurement errors.
In order to understand to what extent this violation of the uniformity assumption affects the estimates of the FDR, we adapted Jager and Leek's simulation as shown in their Figure 5(a) . In their simulation, p-values for studies where the alternative hypothesis is true draw from a beta distribution and p-values for studies where the null hypothesis is true draw from a uniform distribution. In our adaptation, we sampled with replacement the p-values for studies where the null hypothesis holds from the empirical p-value distribution we observed in our experiment (see Figure 1) . Figure 2 presents the result of our simulation Figure 1 . study, indicating that the estimated FDR is not informative about the true FDR. We have added the R code and data to reproduce this figure as supplementary material available at Biostatistics online.
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Fig. 2. Estimated versus SWFDR. We created 100 simulated journals where the p-values reported were all the p-values <0.05. When the alternative hypothesis is true, we draw the p-values from a beta distribution. When the null hypothesis is true, we resampled with replacement the p-values from the p-values observed in real observational analyses, as shown in
In summary, the scope of Jager and Leek's analyses includes " p-hacking" and rounding, but fails to address other threats to the validity of the core uniformity assumption. Our experimental results strongly suggest that these threats substantially impact real-world FDRs.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at http://biostatistics.oxfordjournals.org. 
ACKNOWLEDGMENTS
Conflict of Interest
INTRODUCTION
We would like to thank the discussants for their insight and efforts in producing this entertaining and thoughtful discussion. We believe that they have raised interesting points regarding our analysis and have made valuable contributions that suggest ways to build on our original idea. Our response focuses on four main points: (1) incorporating data into the discussion, (2) the importance of reproducible research, (3) a new statistical formulation for the science-wise false discovery rate (SWFDR), and (4) are most published medical results "true"?
INCORPORATING DATA INTO THE DISCUSSION
One of our primary goals in this manuscript was to identify, collect, and publish a new source of data for evaluating the rate of false discoveries in the medical or scientific literature. Given the stakes-both economic and professional-involved in high-profile medical and scientific research, it is not surprising that there are strong opinions about the actual rate of false discoveries among published results. The
